AIM IMMUNOTECH INC. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$88K
Cost of Revenue
—
R&D
$4M
D&A
$37K
Operating Income
$-12M
EBITDA
$-12M
Interest Expense
$812K
Other Income/Expense
$-1M
Pretax Income
$-14M
Net Income
$-14M
Operating Margin
-13254.5%
Net Margin
-15861.4%
Deferred Tax Assets
—
DTA Valuation Allowance
$47M
Tax Credit Carryforwards
$3M
NOL Carryforwards
$34M
ETR (Continuing Operations)
0.0%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
7.6%
ETR Foreign Differential (pp)
-0.0%
Operating Lease Cost
$294K
Revenue YoY Variation
-48.2%
Income YoY Variation
41.0%